Suppr超能文献

[进行性核上性麻痹综合征]

[Segawa disease].

作者信息

Nomura Y

机构信息

Segawa Neurological Clinic for Children.

出版信息

Rinsho Shinkeigaku. 1997 Dec;37(12):1137-8.

PMID:9577670
Abstract

Segawa disease (hereditary progressive dystonia with marked diurnal fluctuation) is an autosomal dominant, childhood onset, postural dystonia and the first hereditary basal ganglia disorder whose causative enzyme and gene defect were clarified. The initial symptom is unilateral pes equinovarus with marked diurnal fluctuation. Progression becomes slower after mid-teens and stationary after thirties. Postural tremor may occur after 10 years of age, especially after thirties. Parkinsonian resting tremor action and torsion dystonia. and disturbed locomotion do not occur. L-Dopa shows marked and sustained effect without side effects. F-Dopa PET and [11C] raclopride PET of over 20-year-old cases are normal. Deficiency of GTP cyclohydrolase I (GCH-I) was suggested from low CSF biopterin and neopterin. Mutation of GCH-I gene and decreased GCH-I were clarified as etiology. Twenty-five mutations discordant among families have been found. Autopsy of a gene proven case revealed decreased striatal tyrosine hydroxylase (TH) and dopamine (DA) in ventral striatum where direct pathway is predominant. Decreased GCH-I causes decreased tetrahydrobiopterin (BH4), TH and DA in nigrostriatal (NS) terminal. The lowest affinity of BH4 to TH causes selective involvement of DA. Postural dystonia is caused by decreased TH and DA affecting D1-direct pathway. Thalamic ventrolateral and pedunculo-pontine nuclei are spared. Diurnal fluctuation of symptoms is due to diurnal fluctuation of TH and DA at NS-DA terminal. Decreased DA to below 20% of normal, shown by polysomnographical studies, and its physiological age related decremental changes in NS-DA terminal underlies characteristic clinical course. High D2 receptor before early thirties masks D1 related hypertonus and manifest progression before 20 years of age. Other pteridine abnormalities also cause dopa responsive postural dystonia with diurnal fluctuation. A case of juvenile parkinsonism without dystonia showed decreased TH in dorsolateral putamen where indirect pathway is predominant. These suggest that decreased TH due to decreased BH4 involves D1-direct pathway causing dystonia, and decreased TH itself involves D2-indirect pathway causing parkinsonism.

摘要

Segawa病(遗传性进行性肌张力障碍伴明显日波动)是一种常染色体显性遗传、儿童期起病的姿势性肌张力障碍,是首个其致病酶和基因缺陷得以明确的遗传性基底神经节疾病。初始症状为单侧马蹄内翻足,且有明显的日波动。青少年中期后进展变缓,30岁后病情稳定。10岁后可能出现姿势性震颤,尤其是30岁后。帕金森病的静止性震颤动作、扭转性肌张力障碍和运动障碍不会出现。左旋多巴显示出显著且持续的疗效,且无副作用。20岁以上病例的氟多巴PET和[11C]雷氯必利PET检查结果正常。脑脊液中生物蝶呤和新蝶呤水平低提示鸟苷三磷酸环化水解酶I(GCH-I)缺乏。GCH-I基因突变和GCH-I减少被明确为病因。已发现25种在不同家族中不一致的突变。一例经基因证实的病例尸检显示,在直接通路占主导的腹侧纹状体中,纹状体酪氨酸羟化酶(TH)和多巴胺(DA)减少。GCH-I减少导致黑质纹状体(NS)终末的四氢生物蝶呤(BH4)、TH和DA减少。BH4对TH的亲和力最低导致DA选择性受累。姿势性肌张力障碍是由TH和DA减少影响D1直接通路所致。丘脑腹外侧核和脚桥核未受累。症状的日波动是由于NS-DA终末处TH和DA的日波动。多导睡眠图研究显示,DA减少至正常水平的20%以下,以及NS-DA终末处其与生理年龄相关的递减变化是其特征性临床病程的基础。30岁前D2受体水平高会掩盖与D1相关的张力亢进,并在20岁前出现明显进展。其他蝶呤异常也会导致伴有日波动的多巴反应性姿势性肌张力障碍。一例无肌张力障碍的青少年帕金森病患者在间接通路占主导的背外侧壳核中TH减少。这些表明,由于BH4减少导致的TH减少涉及D1直接通路,从而引起肌张力障碍,而TH本身减少涉及D2间接通路,从而引起帕金森病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验